{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:21:26Z","timestamp":1794489686649,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Zhuang Autonomous Region Health Commission","award":["Z20190285"],"award-info":[{"award-number":["Z20190285"]}]},{"name":"Liuzhou Science and Technology Bureau","award":["2022CAC0104"],"award-info":[{"award-number":["2022CAC0104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04104-9","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:17:11Z","timestamp":1741151831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute onset of anti-IgLON5 disease with meningeal enhancement: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Huasheng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"issue":"6","key":"4104_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13(6):575\u201386.","journal-title":"Lancet Neurol"},{"issue":"18","key":"4104_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017;88(18):1736\u201343.","journal-title":"Neurology"},{"issue":"5","key":"4104_CR3","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","volume":"4","author":"JA Honorat","year":"2017","unstructured":"Honorat JA, Komorowski L, Josephs KA, et al. IgLON5 antibody: neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm. 2017;4(5):e385.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"4104_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/ene.15117","volume":"29","author":"Y Ni","year":"2022","unstructured":"Ni Y, Shen D, Zhang Y, et al. Expanding the clinical spectrum of anti-IgLON5 disease: A multicenter retrospective study. Eur J Neurol. 2022;29(1):267\u201376.","journal-title":"Eur J Neurol"},{"issue":"3","key":"4104_CR5","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s00415-020-10386-5","volume":"268","author":"C Helmchen","year":"2021","unstructured":"Helmchen C, Wandinger KP, Steffen A, Munte TF, Bruggemann N. Bilateral vestibulopathy in anti-IgLON5 disease. J Neurol. 2021;268(3):1114\u20136.","journal-title":"J Neurol"},{"issue":"1","key":"4104_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/jamaneurol.2019.3638","volume":"77","author":"H Chen","year":"2020","unstructured":"Chen H, Wu J, Irani SR. Distinctive magnetic resonance imaging findings in IgLON5 antibody disease. JAMA Neurol. 2020;77(1):125\u20136.","journal-title":"JAMA Neurol"},{"issue":"4","key":"4104_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1159\/000522234","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li R, Sun X, et al. Anti-IgLON5 encephalopathy with concomitant herpes virus encephalitis. Neuroimmunomodulation. 2022;29(4):515\u20139.","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"4104_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12883-021-02145-4","volume":"21","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wu X, Lu B. Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report. BMC Neurol. 2021;21(1):120.","journal-title":"BMC Neurol"},{"issue":"8","key":"4104_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11940-018-0515-4","volume":"20","author":"A Heidbreder","year":"2018","unstructured":"Heidbreder A, Philipp K. Anti-IgLON 5 disease. Curr Treat Options Neurol. 2018;20(8):29.","journal-title":"Curr Treat Options Neurol"},{"key":"4104_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fneur.2018.00329","volume":"9","author":"M Montagna","year":"2018","unstructured":"Montagna M, Amir R, De Volder I, Lammens M, Huyskens J, Willekens B. IgLON5-Associated encephalitis with atypical brain magnetic resonance imaging and cerebrospinal fluid changes. Front Neurol. 2018;9:329.","journal-title":"Front Neurol"},{"issue":"7","key":"4104_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/epi.16571","volume":"61","author":"C Steriade","year":"2020","unstructured":"Steriade C, Britton J, Dale RC, et al. Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions. Epilepsia. 2020;61(7):1341\u201351.","journal-title":"Epilepsia"},{"key":"4104_CR12","doi-asserted-by":"crossref","unstructured":"Erro ME, Sabater L, Martinez L et al. Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy. Neurol Neuroimmunol Neuroinflamm. 2020;7(2).","DOI":"10.1212\/NXI.0000000000000651"},{"issue":"4","key":"4104_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","volume":"132","author":"E Gelpi","year":"2016","unstructured":"Gelpi E, Hoftberger R, Graus F, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132(4):531\u201343.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"4104_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00401-023-02625-6","volume":"146","author":"E Berger-Sieczkowski","year":"2023","unstructured":"Berger-Sieczkowski E, Endmayr V, Haider C, et al. Analysis of inflammatory markers and Tau deposits in an autopsy series of nine patients with anti-IgLON5 disease. Acta Neuropathol. 2023;146(4):631\u201345.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"4104_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","volume":"13","author":"L Sabater","year":"2016","unstructured":"Sabater L, Planaguma J, Dalmau J, Graus F. Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome. J Neuroinflammation. 2016;13(1):226.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"4104_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/WCO.0000000000000677","volume":"32","author":"C Gaig","year":"2019","unstructured":"Gaig C, Compta Y. Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease. Curr Opin Neurol. 2019;32(3):493\u20139.","journal-title":"Curr Opin Neurol"},{"key":"4104_CR17","doi-asserted-by":"publisher","first-page":"1329540","DOI":"10.3389\/fimmu.2023.1329540","volume":"14","author":"S Sun","year":"2023","unstructured":"Sun S, Ren J, Zhong Z, et al. Case report: overlapping anti-AMPAR encephalitis with anti-IgLON5 disease post herpes simplex virus encephalitis. Front Immunol. 2023;14:1329540.","journal-title":"Front Immunol"},{"issue":"4","key":"4104_CR18","doi-asserted-by":"publisher","first-page":"e24384","DOI":"10.1097\/MD.0000000000024384","volume":"100","author":"Y Pi","year":"2021","unstructured":"Pi Y, Zhang LL, Li JC. Anti-IgLON5 disease with distinctive brain MRI findings responding to immunotherapy: A case report. Med (Baltim). 2021;100(4):e24384.","journal-title":"Med (Baltim)"},{"issue":"7","key":"4104_CR19","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00415-020-09924-y","volume":"267","author":"T Gruter","year":"2020","unstructured":"Gruter T, Behrendt V, Bien CI, Gold R, Ayzenberg I. Early immunotherapy is highly effective in IgG1\/IgG4 positive IgLON5 disease. J Neurol. 2020;267(7):2151\u20133.","journal-title":"J Neurol"},{"issue":"4","key":"4104_CR20","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00415-019-09221-3","volume":"266","author":"K Logmin","year":"2019","unstructured":"Logmin K, Moldovan AS, Elben S, Schnitzler A, Groiss SJ. Intravenous Immunoglobulins as first-line therapy for IgLON5 encephalopathy. J Neurol. 2019;266(4):1031\u20133.","journal-title":"J Neurol"},{"issue":"4","key":"4104_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/ane.13207","volume":"141","author":"P Cabezudo-Garcia","year":"2020","unstructured":"Cabezudo-Garcia P, Mena-Vazquez N, Estivill TG, Serrano-Castro P. Response to immunotherapy in anti-IgLON5 disease: A systematic review. Acta Neurol Scand. 2020;141(4):263\u201370.","journal-title":"Acta Neurol Scand"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04104-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04104-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04104-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:54:33Z","timestamp":1741193673000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04104-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4104"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04104-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was was in accordance with the ethical standards of Liuzhou People\u2019s Hospital affiliated to Guangxi Medical University and with the Helsinki declaration. The patient provided written informed consent according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patient gave written informed consent for their personal or clinical details and any identifying images to be published in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}